Literature DB >> 623255

Experimental validation of measurements of glucose turnover in nonsteady state.

J Radziuk, K H Norwich, M Vranic.   

Abstract

The aim of the present experiments is to validate, in conscious dogs, the tracer infusion methods of measuring nonsteady turnover rates. This was done in nine experiments performed in four normal dogs by infusing isotopically labeled glucose (2-3H, 6-3H, 1-14C) and monitoring the concentrations of both the labeled and unlabeled substances. The validation is based on the observation that a high exogenous infusion of glucose will suppress endogenous glucose production and become the sole source of glucose in the body. By infusing glucose at a high, time-varying rate, calculating its rate of appearance, (Ra) and comparing it to the infused rate, the method can be verified. The calculations were based on: a) a single-compartment model with a modified volume of distribution; b) a two-compartment model; and c) a generalized dispersion model. The absolute values of the areas of the deviations of the calculated from the infused curves were found to be, respectively, 9.5, 8.4, and 7.8 percent of the total area under the infused curve. It was concluded that the tracer infusion method can reliably measure Ra of glucose when it is changing rapidly, and the system is out of steady state.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 623255     DOI: 10.1152/ajpendo.1978.234.1.E84

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  78 in total

1.  Defective glucose utilization in patients with functioning beta-cell tumors persists after tumor excision.

Authors:  G S McGee; M M Kulaylat; N N Abumrad
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

2.  Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation.

Authors:  S Attvall; J Fowelin; H von Schenck; I Lager; U Smith
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

3.  Use of labeled oral minimal model to measure hepatic insulin sensitivity.

Authors:  Chiara Dalla Man; Gianna Toffolo; Rita Basu; Robert A Rizza; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-02       Impact factor: 4.310

Review 4.  Stable isotope-based flux studies in nonalcoholic fatty liver disease.

Authors:  Arthur McCullough; Stephen Previs; Takhar Kasumov
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

5.  Effect of insulin on the distribution and disposition of glucose in man.

Authors:  E Ferrannini; J D Smith; C Cobelli; G Toffolo; A Pilo; R A DeFronzo
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Beta-adrenergic blockade is more effective in suppressing adrenaline-induced glucose production in Type 1 (insulin-dependent) diabetes.

Authors:  H Shamoon; R Sherwin
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

7.  Effect of ketone bodies on glucose production and utilization in the miniature pig.

Authors:  M J Müller; U Paschen; H J Seitz
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

8.  Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle.

Authors:  J Eriksson; L Koranyi; R Bourey; C Schalin-Jäntti; E Widén; M Mueckler; A M Permutt; L C Groop
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

9.  Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used.

Authors:  P M Bell; R G Firth; R A Rizza
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

10.  The effect of systemic venous drainage of the pancreas on insulin sensitivity in dogs.

Authors:  J Radziuk; P Barron; H Najm; J Davies
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.